These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2249327)
1. The effect of cimetidine on cyclophosphamide metabolism in rabbits. Anthony LB; Long QC; Struck RF; Hande KR Cancer Chemother Pharmacol; 1990; 27(2):125-30. PubMed ID: 2249327 [TBL] [Abstract][Full Text] [Related]
2. Half-life of oxazaphosphorines in biological fluids. Sladek NE; Powers JF; Grage GM Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904 [TBL] [Abstract][Full Text] [Related]
3. Isolation and mass spectral identification of blood metabolites of cyclophosphamide: evidence for phosphoramide mustard as the biologically active metabolite. Struck RF; Kirk MC; Witt MH; Laster WR Biomed Mass Spectrom; 1975 Feb; 2(1):46-52. PubMed ID: 1131393 [TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation. Sladek NE; Doeden D; Powers JF; Krivit W Cancer Treat Rep; 1984 Oct; 68(10):1247-54. PubMed ID: 6395951 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat. Hong PS; Srigritsanapol A; Chan KK Drug Metab Dispos; 1991; 19(1):1-7. PubMed ID: 1673381 [TBL] [Abstract][Full Text] [Related]
6. Individual variation in the activation and inactivation of metabolic pathways of cyclophosphamide. Boddy AV; Furtun Y; Sardas S; Sardas O; Idle JR J Natl Cancer Inst; 1992 Nov; 84(22):1744-8. PubMed ID: 1433359 [TBL] [Abstract][Full Text] [Related]
7. The effects of cimetidine upon the plasma pharmacokinetics of doxorubicin in rabbits. Brenner DE; Collins JC; Hande KR Cancer Chemother Pharmacol; 1986; 18(3):219-22. PubMed ID: 3802377 [TBL] [Abstract][Full Text] [Related]
8. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice. Hemminki K Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012 [TBL] [Abstract][Full Text] [Related]
9. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis. Low JE; Borch RF; Sladek NE Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of cyclophosphamide in paediatric patients. Tasso MJ; Boddy AV; Price L; Wyllie RA; Pearson AD; Idle JR Cancer Chemother Pharmacol; 1992; 30(3):207-11. PubMed ID: 1628369 [TBL] [Abstract][Full Text] [Related]
11. Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans. Jarman M; Milsted RA; Smyth JF; Kinas RW; Pankiewicz K; Stec WJ Cancer Res; 1979 Jul; 39(7 Pt 1):2762-7. PubMed ID: 445480 [TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide metabolism in children. Yule SM; Boddy AV; Cole M; Price L; Wyllie R; Tasso MJ; Pearson AD; Idle JR Cancer Res; 1995 Feb; 55(4):803-9. PubMed ID: 7850793 [TBL] [Abstract][Full Text] [Related]
13. Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation. Chen TL; Kennedy MJ; Anderson LW; Kiraly SB; Black KC; Colvin OM; Grochow LB Drug Metab Dispos; 1997 May; 25(5):544-51. PubMed ID: 9152592 [TBL] [Abstract][Full Text] [Related]
14. Phenotypically deficient urinary elimination of carboxyphosphamide after cyclophosphamide administration to cancer patients. Hadidi AH; Coulter CE; Idle JR Cancer Res; 1988 Sep; 48(18):5167-71. PubMed ID: 3409242 [TBL] [Abstract][Full Text] [Related]
15. Determination of cyclophosphamide metabolites by gas chromatography and thermionic specific detection. Interindividual differences in hepatic biotransformation of cyclophosphamide in man in vitro. Sessink PJ; Vaes WH; van den Broek PH; Noordhoek J; Bos RP J Chromatogr B Biomed Appl; 1995 Nov; 673(2):205-12. PubMed ID: 8611954 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of cyclophosphamide and cyclophosphamide metabolites in the mouse and their influence on the therapeutic effect of "activated" cyclophosphamide (4-hydroxycyclophosphamide) (author's transl)]. Voelcker G; Haeglsperger R Arzneimittelforschung; 1982; 32(6):639-47. PubMed ID: 7202370 [TBL] [Abstract][Full Text] [Related]
17. [Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)]. Wagner T; Heydrich D; Voelcker G; Hohorst HJ J Cancer Res Clin Oncol; 1980 Jan; 96(1):79-92. PubMed ID: 7358774 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508. Chan KK; Hong PS; Tutsch K; Trump DL Cancer Res; 1994 Dec; 54(24):6421-9. PubMed ID: 7987837 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients. Ren S; Kalhorn TF; McDonald GB; Anasetti C; Appelbaum FR; Slattery JT Clin Pharmacol Ther; 1998 Sep; 64(3):289-301. PubMed ID: 9757153 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450. Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]